Fosinopril Sodium , ≥99% , 88889-14-9
Synonym(s):
Fosinopril;Monopril;Secorvas;Staril;(2S,4S)-4-Cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid
CAS NO.：88889-14-9
Empirical Formula: C30H46NNaO7P
Molecular Weight: 586.65
MDL number: MFCD00897699
EINECS: 1312995-182-4
| Pack Size | Price | Stock | Quantity |
| 25MG | RMB39.20 | In Stock |
|
| 100MG | RMB68.00 | In Stock |
|
| 250mg | RMB84.00 | In Stock |
|
| 500MG | RMB135.20 | In Stock |
|
| 1g | RMB280.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 196-198°C |
| storage temp. | Inert atmosphere,Store in freezer, under -20°C |
| solubility | H2O: >20mg/mL |
| form | powder |
| color | white to off-white |
Description and Uses
Fosinopril sodium, an ester prodrug of fosinoprilat, is the first of a new generation of phosphinic acid ACE inhibitors indicated for the once-daily treatment of hypertension. Unlike captopril and lisinopril, it is reportedly effective in increasing the left ventricular peak filling rates and peak ejection rates in hypertensive patients at rest. Another advantage is that fosinopril sodium is metabolized equally by renal and hepatic routes, thereby avoiding the requirement to modify dosage in patients with renal insufficiency.
A labelled phosphinic acid containing angiotensin converting enzyme (ACE) inhibitor.
Safety
| Symbol(GHS) |   GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H319-H361d |
| Precautionary statements | P202-P264-P280-P305+P351+P338-P308+P313-P337+P313 |
| WGK Germany | 3 |
| HS Code | 2933995300 |
